A Novel Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Gamma Mutation Identified in an Incontinentia Pigmenti Patient with Syndromic Tooth Agenesis.

Shichen Sun,Fang Li,Yang Liu,Hong Qu,Sing-Wai Wong,Li Zeng,Miao Yu,Hailan Feng,Haochen Liu,Dong Han
DOI: https://doi.org/10.1016/j.archoralbio.2019.03.013
IF: 2.64
2019-01-01
Archives of Oral Biology
Abstract:Objective: To explore the gene mutation in an incontinentia pigmenti (IP) patient with syndromic tooth agenesis. Methods: Long-range polymerase chain reaction (PCR) and Sanger sequencing were used to detect inhibitor of nuclear factor kappa-B kinase subunit gamma (IKBKG) mutation in the IP patient. We used the nuclear factor kappa B (NF-kappa B) reporter gene to assess activation of NF-kappa B, after transfecting an empty vector, wild-type, or mutant NF-kappa B essential modulator (NEMO) plasmid into IKBKG-deficient HEK293T cells, respectively. Furthermore, we performed immunoprecipitation and immunoblotting to describe the polyubiquitination of NEMO. Lastly, we detected the interactions between mutant NEMO and I kappa B kinase alpha (IKK alpha), I kappa B kinase beta (IKK beta), TNF receptor associated factor 6 (TRAF6), HOIL-1-interacting protein (HOIP), hemo-oxidized iron regulatory protein 2 ligase 1 (HOIL-1), and SHANK-associated RH domain interactor (SHARPIN). Results: A de novo nonsense mutation in IKBKG (c.924C > G; p.Tyr308*) was observed. The Tyr308* mutation inhibited activation of the NF-kappa B pathway by reducing K63-linked polyubiquitination and linear polyubiquitination. The mutant NEMO was not able to interact with TRAF6, HOIL-1, or SHARPIN. Conclusions: We identified a novel nonsense IKBKG mutation (c.924C > G; p.Tyr308*) in an IP patient with syndromic tooth agenesis. This research enriches the mutation spectrum of the IKBKG gene.
What problem does this paper attempt to address?